Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;84:489-497

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, A. M.
Right arrow Articles by Stern, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, A. M.
Right arrow Articles by Stern, D.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Receptor pharmacology
Right arrow Other Vascular biology
(Circulation Research. 1999;84:489-497.)
© 1999 American Heart Association, Inc.


Mini Review

Activation of Receptor for Advanced Glycation End Products

A Mechanism for Chronic Vascular Dysfunction in Diabetic Vasculopathy and Atherosclerosis

Ann Marie Schmidt, Shi Du Yan, Jean-Luc Wautier, David Stern

From the Division of Surgical Science, Departments of Surgery (A.M.S., D.S.), Medicine (A.M.S.), Pathology (S.D.Y.), and Physiology (D.S.) and Cellular Biophysics (A.M.S., S.D.Y, D.S.), College of Physicians & Surgeons of Columbia University, New York, NY, and Laboratoire de Biologie Vasculaire et Cellulaire (J-L.W.), UFR Lariboisiere St Louis, Paris, France.

Correspondence to Dr Ann Marie Schmidt, Department of Surgery, P&S 17-501, College of Physicians & Surgeons of Columbia University, 630 W 168th St, New York, NY 10032.

Abstract

Abstract—Receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin superfamily of cell surface molecules and engages diverse ligands relevant to distinct pathological processes. One class of RAGE ligands includes glycoxidation products, termed advanced glycation end products, which occur in diabetes, at sites of oxidant stress in tissues, and in renal failure and amyloidoses. RAGE also functions as a signal transduction receptor for amyloid ß peptide, known to accumulate in Alzheimer disease in both affected brain parenchyma and cerebral vasculature. Interaction of RAGE with these ligands enhances receptor expression and initiates a positive feedback loop whereby receptor occupancy triggers increased RAGE expression, thereby perpetuating another wave of cellular activation. Sustained expression of RAGE by critical target cells, including endothelium, smooth muscle cells, mononuclear phagocytes, and neurons, in proximity to these ligands, sets the stage for chronic cellular activation and tissue damage. In a model of accelerated atherosclerosis associated with diabetes in genetically manipulated mice, blockade of cell surface RAGE by infusion of a soluble, truncated form of the receptor completely suppressed enhanced formation of vascular lesions. Amelioration of atherosclerosis in these diabetic/atherosclerotic animals by soluble RAGE occurred in the absence of changes in plasma lipids or glycemia, emphasizing the contribution of a lipid- and glycemia-independent mechanism(s) to atherogenesis, which we postulate to be interaction of RAGE with its ligands. Future studies using mice in which RAGE expression has been genetically manipulated and with selective low molecular weight RAGE inhibitors will be required to definitively assign a critical role for RAGE activation in diabetic vasculopathy. However, sustained receptor expression in a microenvironment with a plethora of ligand makes possible prolonged receptor stimulation, suggesting that interaction of cellular RAGE with its ligands could be a factor contributing to a range of important chronic disorders.


Key Words: glycoxidation • diabetes • nuclear factor-{kappa}B • inflammation • amyloid




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
L. P. Kihm, D. Wibisono, S. Muller-Krebs, F. Pfisterer, C. Morath, M. L. Gross, M. Morcos, Y. Seregin, A. Bierhaus, P. P. Nawroth, et al.
RAGE expression in the human peritoneal membrane
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3302 - 3306.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Shanmugam, J. L. Figarola, Y. Li, P. M. Swiderski, S. Rahbar, and R. Natarajan
Proinflammatory Effects of Advanced Lipoxidation End Products in Monocytes
Diabetes, April 1, 2008; 57(4): 879 - 888.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Toth, L. L. Rong, C. Yang, J. Martinez, F. Song, N. Ramji, V. Brussee, W. Liu, J. Durand, M. D. Nguyen, et al.
Receptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy
Diabetes, April 1, 2008; 57(4): 1002 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
H. Zhou, K. C. Tan, S. W. Shiu, and Y. Wong
Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy
Nephrol. Dial. Transplant., March 1, 2008; 23(3): 927 - 933.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. M. Englert, L. E. Hanford, N. Kaminski, J. M. Tobolewski, R. J. Tan, C. L. Fattman, L. Ramsgaard, T. J. Richards, I. Loutaev, P. P. Nawroth, et al.
A Role for the Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis
Am. J. Pathol., March 1, 2008; 172(3): 583 - 591.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Gundewar, J. W. Calvert, J. W. Elrod, and D. J. Lefer
Cytoprotective effects of N,N,N-trimethylsphingosine during ischemia- reperfusion injury are lost in the setting of obesity and diabetes
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2462 - H2471.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. de Leeuw, R. Graaff, R. de Vries, R. P. Dullaart, A. J. Smit, C. G. Kallenberg, and M. Bijl
Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus
Rheumatology, October 1, 2007; 46(10): 1551 - 1556.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
O. Kaloudi, G. Basta, F. Perfetto, F. Bartoli, A. Del Rosso, I. Miniati, M. L. Conforti, S. Generini, S. Guiducci, R. Abbate, et al.
Circulating levels of N{varepsilon}-(carboxymethyl)lysine are increased in systemic sclerosis
Rheumatology, March 1, 2007; 46(3): 412 - 416.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J.-H. Oak and H. Cai
Attenuation of Angiotensin II Signaling Recouples eNOS and Inhibits Nonendothelial NOX Activity in Diabetic Mice
Diabetes, January 1, 2007; 56(1): 118 - 126.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Koyama, T. Shoji, S. Fukumoto, K. Shinohara, T. Shoji, M. Emoto, K. Mori, H. Tahara, E. Ishimura, R. Kakiya, et al.
Low Circulating Endogenous Secretory Receptor for AGEs Predicts Cardiovascular Mortality in Patients With End-Stage Renal Disease
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 147 - 153.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Goldin, J. A. Beckman, A. M. Schmidt, and M. A. Creager
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Circulation, August 8, 2006; 114(6): 597 - 605.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Chen and M. S. Goligorsky
Premature senescence of endothelial cells: Methusaleh's dilemma
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1729 - H1739.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Uchida, M. Shirasawa, L. B. Ware, K. Kojima, Y. Hata, K. Makita, G. Mednick, Z. A. Matthay, and M. A. Matthay
Receptor for Advanced Glycation End-Products Is a Marker of Type I Cell Injury in Acute Lung Injury
Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 1008 - 1015.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. B. Marrero, A. K. Banes-Berceli, D. M. Stern, and D. C. Eaton
Role of the JAK/STAT signaling pathway in diabetic nephropathy
Am J Physiol Renal Physiol, April 1, 2006; 290(4): F762 - F768.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. A. Klibansky, A. Chin, I. J. Duignan, and J. M. Edelberg
Synergistic targeting with bone marrow-derived cells and PDGF improves diabetic vascular function
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1387 - H1392.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Chen, X. Huang, D. Halicka, S. Brodsky, A. Avram, J. Eskander, N. A. Bloomgarden, Z. Darzynkiewicz, and M. S. Goligorsky
Contribution of p16INK4a and p21CIP1 pathways to induction of premature senescence of human endothelial cells: permissive role of p53
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1575 - H1586.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. G. Walker, J. Link, L.-F. Lue, J. E. Dalsing-Hernandez, and B. E. Boyes
Gene expression changes by amyloid {beta} peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes
J. Leukoc. Biol., March 1, 2006; 79(3): 596 - 610.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Asbun and F. J. Villarreal
The Pathogenesis of Myocardial Fibrosis in the Setting of Diabetic Cardiomyopathy
J. Am. Coll. Cardiol., February 21, 2006; 47(4): 693 - 700.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. De Caterina, A. Zampolli, S. Del Turco, R. Madonna, and M. Massaro
Nutritional mechanisms that influence cardiovascular disease
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 421S - 426S.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
V. Schwenger, C. Morath, A. Salava, K. Amann, Y. Seregin, R. Deppisch, E. Ritz, A. Bierhaus, P. P. Nawroth, and M. Zeier
Damage to the Peritoneal Membrane by Glucose Degradation Products Is Mediated by the Receptor for Advanced Glycation End-Products
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 199 - 207.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Aragno, R. Mastrocola, C. Medana, F. Restivo, M. G. Catalano, N. Pons, O. Danni, and G. Boccuzzi
Up-Regulation of Advanced Glycated Products Receptors in the Brain of Diabetic Rats Is Prevented by Antioxidant Treatment
Endocrinology, December 1, 2005; 146(12): 5561 - 5567.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Koyama, T. Shoji, H. Yokoyama, K. Motoyama, K. Mori, S. Fukumoto, M. Emoto, T. Shoji, H. Tamei, H. Matsuki, et al.
Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2587 - 2593.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Lawrie, E. Spiekerkoetter, E. C. Martinez, N. Ambartsumian, W. J. Sheward, M. R. MacLean, A. J. Harmar, A.-M. Schmidt, E. Lukanidin, and M. Rabinovitch
Interdependent Serotonin Transporter and Receptor Pathways Regulate S100A4/Mts1, a Gene Associated With Pulmonary Vascular Disease
Circ. Res., August 5, 2005; 97(3): 227 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. S. Jensen, B. Feldt-Rasmussen, K. Borch-Johnsen, K. S. Jensen, and B. G. Nordestgaard
Increased Transvascular Lipoprotein Transport in Diabetes: Association with Albuminuria and Systolic Hypertension
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4441 - 4445.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Harris
Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy: It's All the RAGE
J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2251 - 2253.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Pamplona, E. Dalfo, V. Ayala, M. J. Bellmunt, J. Prat, I. Ferrer, and M. Portero-Otin
Proteins in Human Brain Cortex Are Modified by Oxidation, Glycoxidation, and Lipoxidation: EFFECTS OF ALZHEIMER DISEASE AND IDENTIFICATION OF LIPOXIDATION TARGETS
J. Biol. Chem., June 3, 2005; 280(22): 21522 - 21530.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Falcone, E. Emanuele, A. D'Angelo, M. P. Buzzi, C. Belvito, M. Cuccia, and D. Geroldi
Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men
Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1032 - 1037.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. D. Beishuizen, M. A. van de Ree, J. W. Jukema, J. T. Tamsma, J. C. M. van der Vijver, A. E. Meinders, H. Putter, and M. V. Huisman
Two-Year Statin Therapy Does Not Alter the Progression of Intima-Media Thickness in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease
Diabetes Care, December 1, 2004; 27(12): 2887 - 2892.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
D. J Collinson, R. Rea, and R. Donnelly
Masterclass series in peripheral arterial disease: Vascular risk: diabetes
Vascular Medicine, November 1, 2004; 9(4): 307 - 310.
[PDF]


Home page
HeartHome page
A Heidland, K Sebekova, A Frangiosa, L S De Santo, M Cirillo, F Rossi, M Cotrufo, A Perna, A Klassen, R Schinzel, et al.
Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation
Heart, November 1, 2004; 90(11): 1269 - 1274.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Kornerup, B. G. Nordestgaard, T. K. Jensen, B. Feldt-Rasmussen, J. P. Eiberg, K. S. Jensen, and J. S. Jensen
Transendothelial exchange of low-density lipoprotein is unaffected by the presence of severe atherosclerosis
Cardiovasc Res, November 1, 2004; 64(2): 337 - 345.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Marx, D. Walcher, N. Ivanova, K. Rautzenberg, A. Jung, R. Friedl, V. Hombach, R. de Caterina, G. Basta, M.-P. Wautier, et al.
Thiazolidinediones Reduce Endothelial Expression of Receptors for Advanced Glycation End Products
Diabetes, October 1, 2004; 53(10): 2662 - 2668.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
E. Selvin, S. Marinopoulos, G. Berkenblit, T. Rami, F. L. Brancati, N. R. Powe, and S. H. Golden
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
Ann Intern Med, September 21, 2004; 141(6): 421 - 431.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Prasad and A. A. Quyyumi
Renin-Angiotensin System and Angiotensin Receptor Blockers in the Metabolic Syndrome
Circulation, September 14, 2004; 110(11): 1507 - 1512.
[Full Text] [PDF]


Home page
Hum ReprodHome page
H. Konishi, M. Nakatsuka, C. Chekir, S. Noguchi, Y. Kamada, A. Sasaki, and Y. Hiramatsu
Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts
Hum. Reprod., September 1, 2004; 19(9): 2156 - 2162.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Basta, A. M. Schmidt, and R. De Caterina
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
Cardiovasc Res, September 1, 2004; 63(4): 582 - 592.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Cai, J. C. He, L. Zhu, M. Peppa, C. Lu, J. Uribarri, and H. Vlassara
High Levels of Dietary Advanced Glycation End Products Transform Low-Density Lipoprotein Into a Potent Redox-Sensitive Mitogen-Activated Protein Kinase Stimulant in Diabetic Patients
Circulation, July 20, 2004; 110(3): 285 - 291.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. F. Hou, H. Ren, W. F. Owen Jr, Z. J. Guo, P. Y. Chen, A. M. Schmidt, T. Miyata, and X. Zhang
Enhanced Expression of Receptor for Advanced Glycation End Products in Chronic Kidney Disease
J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1889 - 1896.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
F. R. DANESH and Y. S. KANWAR
Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy
FASEB J, May 1, 2004; 18(7): 805 - 815.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. V. Brodsky, O. Gealekman, J. Chen, F. Zhang, N. Togashi, M. Crabtree, S. S. Gross, A. Nasjletti, and M. S. Goligorsky
Prevention and Reversal of Premature Endothelial Cell Senescence and Vasculopathy in Obesity-Induced Diabetes by Ebselen
Circ. Res., February 20, 2004; 94(3): 377 - 384.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Marfella, C. Di Filippo, K. Esposito, F. Nappo, E. Piegari, S. Cuzzocrea, L. Berrino, F. Rossi, D. Giugliano, and M. D'Amico
Absence of Inducible Nitric Oxide Synthase Reduces Myocardial Damage During Ischemia Reperfusion in Streptozotocin-Induced Hyperglycemic Mice
Diabetes, February 1, 2004; 53(2): 454 - 462.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. Bouma, L. M. J. Kroon-Batenburg, Y.-P. Wu, B. Brunjes, G. Posthuma, O. Kranenburg, P. G. de Groot, E. E. Voest, and M. F. B. G. Gebbink
Glycation Induces Formation of Amyloid Cross-{beta} Structure in Albumin
J. Biol. Chem., October 24, 2003; 278(43): 41810 - 41819.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Culbertson, E. I. Vassilenko, L. D. Morrison, and Keith. U. Ingold
Paradoxical Impact of Antioxidants on Post-Amadori Glycoxidation: COUNTERINTUITIVE INCREASE IN THE YIELDS OF PENTOSIDINE AND N{epsilon}-CARBOXYMETHYLLYSINE USING A NOVEL MULTIFUNCTIONAL PYRIDOXAMINE DERIVATIVE
J. Biol. Chem., October 3, 2003; 278(40): 38384 - 38394.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. A. Creager, T. F. Luscher, F. Cosentino, and J. A. Beckman
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I
Circulation, September 23, 2003; 108(12): 1527 - 1532.
[Full Text] [PDF]


Home page
Diabetes CareHome page
T. A. Ciulla, A. G. Amador, and B. Zinman
Diabetic Retinopathy and Diabetic Macular Edema: Pathophysiology, screening, and novel therapies
Diabetes Care, September 1, 2003; 26(9): 2653 - 2664.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
X. JiXiong, X. BiLin, Y. MingGong, and L. ShuQin
-429T/C and -374T/A Polymorphisms of RAGE Gene Promoter Are Not Associated With Diabetic Retinopathy in Chinese Patients With Type 2 Diabetes
Diabetes Care, September 1, 2003; 26(9): 2696 - 2697.
[Full Text] [PDF]


Home page
DiabetesHome page
S. S. Shaw, A. M. Schmidt, A. K. Banes, X. Wang, D. M. Stern, and M. B. Marrero
S100B-RAGE-Mediated Augmentation of Angiotensin II-Induced Activation of JAK2 in Vascular Smooth Muscle Cells Is Dependent on PLD2
Diabetes, September 1, 2003; 52(9): 2381 - 2388.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. S. De Vriese, A. Flyvbjerg, S. Mortier, R. G. Tilton, and N. H. Lameire
Inhibition of the Interaction of AGE-RAGE Prevents Hyperglycemia-Induced Fibrosis of the Peritoneal Membrane
J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2109 - 2118.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K.-H. Mak and D. P. Faxon
Clinical studies on coronary revascularization in patients with type 2 diabetes
Eur. Heart J., June 2, 2003; 24(12): 1087 - 1103.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Morcos, A. A.R. Sayed, A. Bierhaus, B. Yard, R. Waldherr, W. Merz, I. Kloeting, E. Schleicher, S. Mentz, R. F. Abd el Baki, et al.
Activation of Tubular Epithelial Cells in Diabetic Nephropathy
Diabetes, December 1, 2002; 51(12): 3532 - 3544.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Libby and J. Plutzky
Diabetic Macrovascular Disease: The Glucose Paradox?
Circulation, November 26, 2002; 106(22): 2760 - 2763.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Napoli, L. O. Lerman, F. de Nigris, J. Loscalzo, and L. J. Ignarro
Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells
J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1515 - 1522.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Esposito, F. Nappo, R. Marfella, G. Giugliano, F. Giugliano, M. Ciotola, L. Quagliaro, A. Ceriello, and D. Giugliano
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress
Circulation, October 15, 2002; 106(16): 2067 - 2072.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. K. Hansson, P. Libby, U. Schonbeck, and Z.-Q. Yan
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
Circ. Res., August 23, 2002; 91(4): 281 - 291.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. E. Mullick, J. M. McDonald, G. Melkonian, P. Talbot, K. E. Pinkerton, and J. C. Rutledge
Reactive carbonyls from tobacco smoke increase arterial endothelial layer injury
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H591 - H597.
[Abstract] [Full Text] [PDF]

<

Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Kornerup, B. G. Nordestgaard, B. Feldt-Rasmussen, K. Borch-Johnsen, K. S. Jensen, and J. S. Jensen
Transvascular Low-Density Lipoprotein Transport in Patients With Diabetes Mellitus (Type 2): A Noninvasive In Vivo Isotope Technique
Arterioscler. Thromb. Vasc. Biol., July 1, 2002; 22(7): 1168 - 1174.
[Abstract] [Full Text] [PDF]